Study title: Open, uncontrolled. To compare immunogenicity and safety of Eivax B according to vaccination schedules.
Type of medicine: Non-centrally authorised vaccines | |||||
Therapeutic area: Virus Diseases | |||||
Brands: | |||||
MAH holders: | |||||
Assessment: | |||||
Active substance: Hepatitis B Surface Antigen | |||||
ATC code: | |||||
Document link: | |||||
Document date: 2011-09-16 | |||||
Study number: KOR_EUV03 | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |